,"Author: Smith, Geoffrey L.",,,,,,,,,,,
,,,,,,,,,,,,
,"h index = 40 (Of the 137 documents considered for the h-Index, 40 have been cited at least 40 times.)",,,,,,,,,,,
,Note: The h Index considers Scopus documents published after 1995.  ,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,subtotal,>2008,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,7234,727,783,1510,400,9144
2009,"Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane.","Roberts K.L., Breiman A., Carter G.C., Ewles H.A., Hollinshead M., Law M., Smith G.L.",00221317,"The Journal of general virology",90, 7,0,0,0,0,0,0
2009,"Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts","Trilling M., Le V.T.K., Zimmermann A., Ludwig H., Pfeffer K., Sutter G., Smith G.L., Hengel H.",0022538X,"Journal of Virology",83, 8,0,0,0,0,0,0
2008,"Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax","Midgley C.M., Putz M.M., Weber J.N., Smith G.L.",00221317,"Journal of General Virology",89, 12,0,0,0,0,1,1
2008,"Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence","Fahy A.S., Clark R.H., Glyde E.F., Smith G.L.",00221317,"Journal of General Virology",89, 10,0,0,0,0,0,0
2008,"Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection","Jacobs N., Bartlett N.W., Clark R.H., Smith G.L.",00221317,"Journal of General Virology",89, 11,0,0,0,0,1,1
2008,"Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals","Lee L.Y.-H., Smith G.L., Townsend A.R.M., Askonas B.A., Rowland-Jones S., Dong T., Ha D.L.A., Simmons C., De Jong M.D., Chau N.V.V., Schumacher R., Yan C.P., McMichael A.J., Farrar J.J.",00219738,"Journal of Clinical Investigation",118, 10,0,0,1,1,15,16
2008,"Vaccinia virus morphogenesis and dissemination","Roberts K.L., Smith G.L.",0966842X,"Trends in Microbiology",16, 10,0,0,0,0,1,1
2008,"Vaccinia virus proteins A52 and B14 share a Bcl-2-like fold but have evolved to inhibit Nf-?B rather than apoptosis","Graham S.C., Smith G.L., Grimes J.M., Bahar M.W., Cooray S., Chen R.A.-J., Whalen D.M., Abrescia N.G.A., Alderton D., Owens R.J., Stuart D.I.",15537366,"PLoS Pathogens",4, 8,0,0,0,0,5,5
2008,"Inhibition of I?B kinase by vaccinia virus virulence factor B14","Chen R.A.-J., Ryzhakov G., Cooray S., Randow F., Smith G.L.",15537366,"PLoS Pathogens",4, 2,0,0,3,3,6,9
2008,"Structure and function of A41, a vaccinia virus chemokine binding protein.","Bahar M.W., Kenyon J.C., Putz M.M., Abrescia N.G., Pease J.E., Wise E.L., Stuart D.I., Smith G.L., Grimes J.M.",15537374,"PLoS pathogens",4, 1,0,0,0,0,1,1
2008,"Structure and function of A41, a vaccinia virus chemokine binding protein","Bahar M.W., Kenyon J.C., Putz M.M., Abrescia N.G.A., Pease J.E., Wise E.L., Stuart D.I., Smith G.L., Grimes J.M.",15537366,"PLoS Pathogens",4, 1,0,0,0,0,1,1
2007,"Structure of CrmE, a Virus-encoded Tumour Necrosis Factor Receptor","Graham S.C., Bahar M.W., Abrescia N.G.A., Smith G.L., Stuart D.I., Grimes J.M.",00222836,"Journal of Molecular Biology",372, 3,0,1,2,3,3,6
2007,"Vaccinia virus gene F3L encodes an intracellular protein that affects the innate immune response","Froggatt G.C., Smith G.L., Beard P.M.",00221317,"Journal of General Virology",88, 7,0,0,4,4,2,6
2007,"Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus","Huang J., Kotenko S.V., Smirnov S.V., Lewis-Antes A., Balan M., Li W., Tang S., Silke G.V., Putz M.M., Smith G.L.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",104, 23,0,0,6,6,1,7
2007,"Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein","Cooray S., Bahar M.W., Abrescia N.G.A., McVey C.E., Bartlett N.W., Chen R.A.-J., Stuart D.I., Grimes J.M., Smith G.L.",00221317,"Journal of General Virology",88, 6,0,3,18,21,5,26
2007,"Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus virulence","Gubse C., Goodbody R., Ecker A., Brady G., O'Neill L.A.J., Jacobs N., Smith G.L.",00221317,"Journal of General Virology",88, 6,0,0,3,3,2,5
2007,"A new inhibitor of apoptosis from vaccinia virus and eukaryotes.","Gubser C., Bergamaschi D., Hollinshead M., Lu X., van Kuppeveld F.J., Smith G.L.",15537374,"PLoS pathogens",3, 2,0,1,1,2,1,3
2007,"A new inhibitor of apoptosis from vaccinia virus and eukaryotes","Gubser C., Bergamaschi D., Hollinshead M., Lu X., Van Kuppeveld F.J.M., Smith G.L.",15537366,"PLoS Pathogens",3, 2,0,1,0,1,0,1
2007,"Invasive eccrine syringomatous carcinoma in the leg","Sinha M., Smith G., Slater D.N., Vijh V.",00321052,"Plastic and Reconstructive Surgery",119, 1,0,0,0,0,0,0
2006,"Structure/function relationships of CCR8 agonists and antagonists: Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist","Fox J.M., Najarro P., Smith G.L., Struyf S., Proost P., Pease J.E.",00219258,"Journal of Biological Chemistry",281, 48,0,1,4,5,3,8
2006,"Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination","Putz M.M., Midgley C.M., Law M., Smith G.L.",10788956,"Nature Medicine",12, 11,0,7,11,18,7,25
2006,"Genome sequence diversity and clues to the evolution of variola (smallpox) virus","Esposito J.J., Laker M., Li Y., Smith G.L., Meyer H., LeDuc J.W., Wohlhueter R.M., Sammons S.A., Frace A.M., Osborne J.D., Glsen-Rasmussen M., Zhang M., Govil D., Damon I.K., Kline R.",00368075,"Science",313, 5788,0,11,8,19,4,23
2006,"Vaccinia virus kelch protein A55 is a 64 kDa intracellular factor that affects virus-induced cytopathic effect and the outcome of infection in a murine intradermal model","Beard P.M., Froggatt G.C., Smith G.L.",00221317,"Journal of General Virology",87, 6,0,3,3,6,2,8
2006,"Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor","Chen R.A.-J., Jacobs N., Smith G.L.",00221317,"Journal of General Virology",87, 6,0,0,5,5,1,6
2006,"Intradermal immune response after infection with Vaccinia virus","Jacobs N., Chen R.A.-J., Gubser C., Najarro P., Smith G.L.",00221317,"Journal of General Virology",87, 5,1,2,4,6,3,10
2006,"Ligand-induced and nonfusogenic dissolution of a viral membrane","Law M., Carter G.G., Roberts K.L., Hollinshead M., Smith G.L.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",103, 15,5,8,12,20,5,30
2006,"Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue","Najarro P., Gubser C., Hollinshead M., Fox J., Pease J., Smith G.L.",00221317,"Journal of General Virology",87, 4,1,1,0,1,0,2
2006,"B and CTL responses to the ALK protein in patients with ALK-positive ALCL","Ait-Tahar K., Cerundolo V., Banham A.H., Hatton C., Blanchard T., Kusec R., Becker M., Smith G.L., Pulford K.",00207136,"International Journal of Cancer",118, 3,0,2,5,7,3,10
2006,"Detection of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy","Clark R.H., Kenyon J.C., Bartlett N.W., Tscharke D.C., Smith G.L.",00221317,"Journal of General Virology",87, 1,0,6,8,14,1,15
2005,"Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein","Herrero-Martinez E., Roberts K.L., Hollinshead M., Smith G.L.",00221317,"Journal of General Virology",86, 11,2,4,3,7,1,10
2005,"Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy","Putz M.M., Alberini I., Midgley C.M., Manini I., Montomoli E., Smith G.L.",00221317,"Journal of General Virology",86, 11,5,4,4,8,2,15
2005,"Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model","Bartlett N.W., Buttigieg K., Kotenko S.V., Smith G.L.",00221317,"Journal of General Virology",86, 6,8,6,10,16,3,27
2005,"Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans","Carter G.C., Law M., Hollinshead M., Smith G.L.",00221317,"Journal of General Virology",86, 5,12,8,9,17,6,35
2005,"An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model","Law M., Putz M.M., Smith G.L.",00221317,"Journal of General Virology",86, 4,10,8,6,14,3,27
2005,"Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence","Stack J., Haga I.R., Schroder M., Bartlett N.W., Maloney G., Reading P.C., Fitzgerald K.A., Smith G.L., Bowie A.G.",00221007,"Journal of Experimental Medicine",201, 6,29,34,38,72,6,107
2004,"The exit of Vaccinia virus from infected cells","Smith G.L., Law M.",01681702,"Virus Research",106, 2,13,9,11,20,6,39
2004,"Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus.","Law M., Smith G.L.",10643745,"Methods in molecular biology (Clifton, N.J.)",269, ,7,0,1,1,1,9
2004,"A new member of the interleukin 10-related cytokine family encoded by a poxvirus","Bartlett N.W., Dumoutier L., Renauld J.-C., Kotenko S.V., McVey C.E., Lee H.-J., Smith G.L.",00221317,"Journal of General Virology",85, 6,6,1,2,3,1,10
2004,"Yaba-like disease virus protein Y144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-infected actin tails","Law M., Hollinshead M., Lee H.-J., Smith G.L.",00221317,"Journal of General Virology",85, 5,2,2,0,2,0,4
2004,"Poxvirus genomes: A phylogenetic analysis","Gubser C., Hue S., Kellam P., Smith G.L.",00221317,"Journal of General Virology",85, 1,43,12,16,28,9,80
2003,"Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1","Najarro P., Lee H.-J., Fox J., Pease J., Smith G.L.",00221317,"Journal of General Virology",84, 12,5,3,0,3,0,8
2003,"Vaccinia Virus Motility","Smith G.L., Murphy B.J., Law M.",00664227,"Annual Review of Microbiology",57, ,25,5,9,14,1,40
2003,"Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity","Reading P.C., Smith G.L.",0022538X,"Journal of Virology",77, 18,13,2,8,10,2,25
2003,"The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model","Pires de Miranda M., Reading P.C., Tscharke D.C., Murphy B.J., Smith G.L.",00221317,"Journal of General Virology",84, 9,7,5,4,9,3,19
2003,"Vaccinia virus cores are transported on microtubules","Carter G.C., Rodger G., Murphy B.J., Law M., Krauss O., Hollinshead M., Smith G.L.",00221317,"Journal of General Virology",84, 9,20,5,2,7,2,29
2003,"A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection","Reading P.C., Smith G.L.",00221317,"Journal of General Virology",84, 8,8,6,5,11,5,24
2003,"Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans","McConkey S.J., Watkins K., Hannan C.M., Everaere S., Brown K., Kester K.E., Cummings J., Williams J., Heppner D.G., Pathan A., Flanagan K., Reece W.H.H., Arulanantham N., Roberts M.T.M., Roy M., Smith G.L., Schneider J., Peto T., Sinden R.E., Gilbert S.C., Hill A.V.S., Moorthy V.S., Webster D., Dunachie S., Butcher G., Vuola J.M., Blanchard T.J., Gothard P.",10788956,"Nature Medicine",9, 6,201,36,39,75,18,294
2003,"Steroid hormone synthesis by Vaccinia virus suppresses the inflammatory response to infection","Reading P.C., Moore J.B., Smith G.L.",00221007,"Journal of Experimental Medicine",197, 10,8,3,7,10,3,21
2003,"The poxvirus protein A52R targets toll-like receptor signaling complexes to suppress host defense","Harte M.T., Haga I.R., Maloney G., Gray P., Reading P.C., Bartlett N.W., Smith G.L., Bowie A., O'Neill L.A.J.",00221007,"Journal of Experimental Medicine",197, 3,83,30,29,59,10,152
2003,"A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection","Reading P.C., Symons J.A., Smith G.L.",00221767,"Journal of Immunology",170, 3,18,0,4,4,2,24
2002,"The formation and function of extracellular enveloped vaccinia virus","Smith G.L., Vanderplasschen A., Law M.",00221317,"Journal of General Virology",83, 12,89,20,23,43,15,147
2002,"The vaccinia virus C1 2L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model","Symons J.A., Adams E., Tscharke D.C., Reading P.C., Waldmann H., Smith G.L.",00221317,"Journal of General Virology",83, 11,18,3,3,6,0,24
2002,"An investigation of incorporation of cellular antigens into vaccinia virus particles","Krauss O., Hollinshead R., Hollinshead M., Smith G.L.",00221317,"Journal of General Virology",83, 10,14,3,2,5,2,21
2002,"The African swine fever virus protein j4R binds to the alpha chain of nascent polypeptide-associated complex","Goatley L.C., Twigg S.R.F., Miskin J.E., Monaghan P., St-Arnaud R., Smith G.L., Dixon L.K.",0022538X,"Journal of Virology",76, 19,5,1,0,1,1,7
2002,"Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence","Reading P.C., Khanna A., Smith G.L.",00426822,"Virology",292, 2,21,3,1,4,0,25
2002,"The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence","Bartlett N., Symons J.A., Tscharke D.C., Smith G.L.",00221317,"Journal of General Virology",83, 8,20,5,8,13,0,33
2002,"A study of the vaccinia virus interferon-? receptor and its contribution to virus virulence","Symons J.A., Tscharke D.C., Price N., Smith G.L.",00221317,"Journal of General Virology",83, 8,29,6,5,11,3,43
2002,"Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes","Tscharke D.C., Reading P.C., Smith G.L.",00221317,"Journal of General Virology",83, 8,27,8,8,16,1,44
2002,"Smallpox: Anything to declare?","Smith G.L., McFadden G.",14741733,"Nature Reviews Immunology",2, 7,25,3,7,10,3,38
2002,"The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox","Gubser C., Smith G.L.",00221317,"Journal of General Virology",83, 4,35,9,5,14,0,49
2002,"The vaccinia virus B9R protein is a 6 kDa intracellular protein that is non-essential for virus replication and virulence","Price N., Tscharke D.C., Smith G.L.",00221317,"Journal of General Virology",83, 4,5,0,0,0,0,5
2002,"The vaccinia virus soluble interferon-? receptor is a homodimer","Alcami A., Smith G.L.",00221317,"Journal of General Virology",83, 3,17,1,4,5,0,22
2002,"Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface","Rodger G., Smith G.L.",00221317,"Journal of General Virology",83, 2,12,1,2,3,0,15
2002,"Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: Role of the A33R protein in antibody-resistant spread","Law M., Hollinshead R., Smith G.L.",00221317,"Journal of General Virology",83, 1,19,4,6,10,2,31
2002,"The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface","Van Eijl H., Hollinshead M., Rodger G., Zhang W.-H., Smith G.L.",00221317,"Journal of General Virology",83, 1,31,2,4,6,4,41
2002,"Erratum: Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: Role of the A33R protein in antibody-resistant spread (Journal of General Virology (2002) vol. 83 (209-222))","Law M., Hollinshead R., Smith G.L.",00221317,"Journal of General Virology",83, 5,0,0,0,0,0,0
2001,"Induction of CD8+ T-lymphocyte responses to a secreted antigen of Mycobacterium tuberculosis by an attenuated vaccinia virus","Feng C.G., Blanchard T.J., Smith G.L., Hill A.V.S., Britton W.J.",08189641,"Immunology and Cell Biology",79, 6,14,2,1,3,2,19
2001,"Vaccinia virus semaphorin A39R is a 50-55 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model","Gardner J.D., Tscharke D.C., Reading P.C., Smith G.L.",00221317,"Journal of General Virology",82, 9,20,3,1,4,1,25
2001,"The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence","Ng A., Tscharke D.C., Reading P.C., Smith G.L.",00221317,"Journal of General Virology",82, 9,26,3,5,8,0,34
2001,"A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees","Schneider J., Robson K.J., Smith G.L., Hill A.V.S., Thomas A.W., Langermans J.A.M., Gilbert S.C., Blanchard T.J., Twigg S., Naitza S., Hannan C.M., Aidoo M., Crisanti A.",0264410X,"Vaccine",19, 32,32,4,2,6,1,39
2001,"The vaccinia virus superoxide dismutase-like protein (A45R) is a virion component that is nonessential for virus replication","Almazan F., Tscharke D.C., Smith G.L.",0022538X,"Journal of Virology",75, 15,19,2,0,2,0,21
2001,"Vaccinia virus utilizes microtubules for movement to the cell surface","Hollinshead M., Rodger G., Van Eijl H., Law M., Hollinshead R., Vaux D.J.T., Smith G.L.",00219525,"Journal of Cell Biology",154, 2,75,4,4,8,3,86
2001,"A mutational analysis of the vaccinia virus B5R protein","Mathew E.C., Sanderson C.M., Hollinshead R., Smith G.L.",00221317,"Journal of General Virology",82, 5,13,2,3,5,0,18
2001,"Differential processing and presentation of the H-2Db-restricted epitope from two different strains of influenza virus nucleoprotein","Potter P., Tourdot S., Blanchard T., Smith G.L., Gould K.G.",00221317,"Journal of General Virology",82, 5,6,0,0,0,1,7
2001,"The genome sequence of Yaba-like disease virus, a yatapoxvirus","Lee H.-J., Essani K., Smith G.L.",00426822,"Virology",281, 2,64,6,0,6,2,72
2001,"Antibody neutralization of the extracellular enveloped form of vaccinia virus","Law M., Smith G.L.",00426822,"Virology",280, 1,34,5,3,8,5,47
2000,"The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN","Alcami A., Symons J.A., Smith G.L.",0022538X,"Journal of Virology",74, 23,47,13,10,23,6,76
2000,"Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence","Zhang W.-H., Wilcock D., Smith G.L.",0022538X,"Journal of Virology",74, 24,30,1,5,6,4,40
2000,"Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro","Dorrell L., O'Callaghan C.A., Britton W., Hambleton S., McMichael A., Smith G.L., Rowland-Jones S., Blanchard T.J.",0264410X,"Vaccine",19, 2-3,9,0,0,0,0,9
2000,"A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling","Bowie A., Kiss-Toth E., Symons J.A., Smith G.L., Dower S.K., O'Neill L.A.J.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",97, 18,133,27,28,55,9,197
2000,"The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles","Van Eijl H., Hollinshead M., Smith G.L.",00426822,"Virology",271, 1,43,2,3,5,2,50
2000,"Vaccinia virus gene B7R encodes an 18-kDa protein that is resident in the endoplasmic reticulum and affects virus virulence","Price N., Tscharke D.C., Hollinshead M., Smith G.L.",00426822,"Virology",267, 1,6,2,4,6,0,12
2000,"The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles","Sanderson C.M., Hollinshead M., Smith G.L.",00221317,"Journal of General Virology",81, 1,53,4,1,5,1,59
1999,"The effects of targeting the vaccinia virus B5R protein to the endoplasmic reticulum on virus morphogenesis and dissemination","Mathew E.C., Sanderson C.M., Hollinshead R., Hollinshead M., Grimley R., Smith G.L.",00426822,"Virology",265, 1,8,0,1,1,0,9
1999,"Immune modulation by proteins secreted from cells infected by vaccinia virus","Smith G.L., Symons J.A., Alcami A.",09391983,"Archives of Virology, Supplement",, 15,16,2,1,3,1,20
1999,"A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae","Tscharke D.C., Smith G.L.",00221317,"Journal of General Virology",80, 10,27,5,3,8,0,35
1999,"Using confocal microscopy to study virus binding and entry into cells","Vanderplasschen A., Smith G.L.",00766879,"Methods in Enzymology",307, ,5,0,0,0,0,5
1999,"The vaccinia virus A4OR gene product is a nonstructural, type II membrane glycoprotein that is expressed at the cell surface","Wilcock D., Duncan S.A., Traktman P., Zhang W.-H., Smith G.L.",00221317,"Journal of General Virology",80, 8,14,0,1,1,1,16
1999,"Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus ankara boost vaccination regimen","Hanke T., Watkins D.I., Cranage M.P., McMichael A.J., Samuel R.V., Blanchard T.J., Neumann V.C., Allen T.M., Boyson J.E., Sharpe S.A., Cook N., Smith G.L.",0022538X,"Journal of Virology",73, 9,223,11,13,24,8,255
1999,"Vaccines for smallpox.","Blanchard T., Smith G.L., Whittle H.",01406736,"Lancet",354, 9176,1,0,0,0,0,1
1999,"Identification of human herpesvirus 8-specific cytotoxic T-cell responses","Osman M., Gotch F., Kubo T., Gill J., Neipel F., Becker M., Smith G., Weiss R., Gazzard B., Boshoff C.",0022538X,"Journal of Virology",73, 7,55,2,3,5,3,63
1999,"Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors","Alcami A., Khanna A., Paul N.L., Smith G.L.",00221317,"Journal of General Virology",80, 4,48,5,7,12,2,62
1999,"Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation","Rottger S., Frischknecht F., Reckmann I., Smith G.L., Way M.",0022538X,"Journal of Virology",73, 4,57,3,6,9,3,69
1999,"Nuclear and nucleolar localization of an African swine fever virus protein, I14L, that is similar to the herpes simplex virus-encoded virulence factor ICP34.5","Goatley L.C., Marron M.B., Jacobs S.C., Hammond J.M., Miskin J.E., Abrams C.C., Smith G.L., Dixon L.K.",00221317,"Journal of General Virology",80, 3,8,1,0,1,1,10
1999,"Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime","Hanke T., Neumann V.C., Blanchard T.J., Sweeney P., Hill A.V.S., Smith G.L., McMichael A.",0264410X,"Vaccine",17, 6,75,1,1,2,2,79
1999,"Vaccinia virus intracellular mature virions contain only one lipid membrane","Hollinshead M., Vanderplasschen A., Smith G.L., Vaux D.J.",0022538X,"Journal of Virology",73, 2,61,6,8,14,2,77
1999,"Poxvirus chemokine-binding proteins","Smith G.L., Dunn W.",11485493,"European Cytokine Network",10, 2,0,0,0,0,0,0
1999,"Vaccinia virus immune evasion","Smith G.L.",01652478,"Immunology Letters",65, 1-2,26,3,2,5,1,32
1998,"Vaccinia virus induces Ca2+-independent cell-matrix adhesion during the motile phase of infection","Sanderson C.M., Smith G.L.",0022538X,"Journal of Virology",72, 12,7,3,0,3,0,10
1998,"Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use","Plebanski M., Sinden R.E., Hill A.V.S., Gilbert S.C., Schneider J., Hannan C.M., Layton G., Blanchard T., Becker M., Smith G., Butcher G.",00142980,"European Journal of Immunology",28, 12,55,3,1,4,0,59
1998,"Extracellular enveloped vaccinia virus: Entry, egress, and evasion","Smith G.L., Vanderplasschen A.",00652598,"Advances in Experimental Medicine and Biology",440, ,25,5,7,12,2,39
1998,"Vaccinia virus-encoded cytokine receptor binds and neutralizes chicken interferon-?","Puehler F., Weining K.C., Symons J.A., Smith G.L., Staeheli P.",00426822,"Virology",248, 2,15,4,1,5,0,20
1998,"Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope","Vanderplasschen A., Mathew E., Hollinshead M., Sim R.B., Smith G.L.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",95, 13,69,9,8,17,5,91
1998,"Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion","Sanderson C.M., Frischknecht F., Way M., Hollinshead M., Smith G.L.",00221317,"Journal of General Virology",79, 6,65,3,5,8,2,75
1998,"Expression of African swine fever virus envelope protein j13L inhibits vaccinia virus morphogenesis","Jacobs S.C., Dixon L.K., Brookes S.M., Smith G.L.",00221317,"Journal of General Virology",79, 5,2,0,0,0,1,3
1998,"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: Implications for use as a human vaccine","Blanchard T.J., Alcami A., Andrea P., Smith G.L.",00221317,"Journal of General Virology",79, 5,126,21,9,30,10,166
1998,"Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara","Schneider J., Hill A.V.S., Gilbert S.C., Blanchard T.J., Hanke T., Robson K.J., Hannan C.M., Becker M., Sinden R., Smith G.L.",10788956,"Nature Medicine",4, 4,385,27,15,42,10,437
1998,"Poxviruses: Capturing cytokines and chemokines","Alcami A., Symons J.A., Khanna A., Smith G.L.",10445773,"Seminars in Virology",8, 5,31,2,1,3,0,34
1998,"Intracellular and extracellular vaccinia virions enter cells by different mechanisms","Vanderplasschen A., Hollinshead M., Smith G.L.",00221317,"Journal of General Virology",79, 4,67,8,5,13,6,86
1998,"Poxviruses: Interfering with interferon","Smith G.L., Symons J.A., Alcami A.",10445773,"Seminars in Virology",8, 5,39,0,2,2,0,41
1998,"The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation","Mathew E., Sanderson C.M., Hollinshead M., Smith G.L.",0022538X,"Journal of Virology",72, 3,36,2,3,5,0,41
1998,"Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime","Hanke T., Blanchard T.J., Schneider J., Hannan C.M., Becker M., Gilbert S.C., Hill A.V.S., Smith G.L., McMichael A.",0264410X,"Vaccine",16, 5,158,9,6,15,6,179
1998,"The PA influenza virus polymerase subunit is a phosphorylated protein","Sanz-Ezquerro J.J., Santaren J.F., Sierra T., Aragon T., Ortega J., Ortin J., Smith G.L., Nieto A.",00221317,"Journal of General Virology",79, 3,23,4,2,6,1,30
1998,"Virus-induced cell motility","Sanderson C.M., Way M., Smith G.L.",0022538X,"Journal of Virology",72, 2,26,3,3,6,1,33
1998,"Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus","Alcami A., Symons J.A., Collins P.D., Williams T.J., Smith G.L.",00221767,"Journal of Immunology",160, 2,137,6,6,12,5,154
1998,"Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice","Hanke T., McMichael A., Blanchard T.J., Schneider J., Ogg G.S., Tan R., Becker M., Gilbert S.C., Hill A.V.S., Smith G.L.",00221317,"Journal of General Virology",79, 1,62,4,3,7,0,69
1997,"Two centuries of vaccination | Deux siècles de vaccination","Vanderplasschen A., Smith G.L.",00034118,"Annales de Medecine Veterinaire",141, 6,0,0,0,0,0,0
1997,"Vaccinia virion protein VP8, the 25 kDa product of the L4R gene, binds single-stranded DNA and RNA with similar affinity","Bayliss C.D., Smith G.L.",03051048,"Nucleic Acids Research",25, 20,12,1,0,1,0,13
1997,"Vaccinia virus immune evasion","Smith G.L., Symons J.A., Khanna A., Vanderplasschen A., Alcami A.",01052896,"Immunological Reviews",159, ,127,4,9,13,5,145
1997,"Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation","Vanderplasschen A., Hollinshead M., Smith G.L.",00221317,"Journal of General Virology",78, 8,29,3,5,8,2,39
1997,"Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-?1 and IFN-?2","Liptakova H., Kontsekova E., Alcami A., Smith G.L., Kontsek P.",00426822,"Virology",232, 1,15,5,1,6,0,21
1997,"A novel virus binding assay using confocal microscopy: Demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors","Vanderplasschen A., Smith G.L.",0022538X,"Journal of Virology",71, 5,67,4,4,8,2,77
1997,"Vaccinia virus serpin B13R(SPI-2) inhibits interleukin-1?-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1?-induced fever","Kettle S., Alcami A., Khanna A., Ehret R., Jassoy C., Smith G.L.",00221317,"Journal of General Virology",78, 3,81,4,5,9,2,92
1997,"Enhanced immunogenicity for CTL induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara encoding pre-erythrocytic","Schneider J., Gilbert S.C., Blanchard T., Hanke T., Sinden R., Robson K.J., Smith G., Hill A.V.S.",01712985,"Immunobiology",197, 2-4,0,0,0,0,0,0
1996,"Overexpression of the vaccinia virus A38L integral membrane protein promotes Ca2+ influx into infected cells","Sanderson C.M., Parkinson J.E., Hollinshead M., Smith G.L.",0022538X,"Journal of Virology",70, 2,32,4,1,5,0,37
1996,"Future vaccines for HIV [17]","Blanchard T., Rowland-Jones S., Gotch F., McMichael A., Smith G.L.",01406736,"Lancet",348, 9043,2,0,0,0,0,2
1996,"Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus","McIntosh A.A.G., Smith G.L.",0022538X,"Journal of Virology",70, 1,70,1,7,8,3,81
1996,"Administration of restorable virtual path mesh networks","Veitch P., Hawker I., Smith G.",01636804,"IEEE Communications Magazine",34, 12,10,2,0,2,0,12
1996,"Stimulation of vaccinia virion DNA helicase 18R, but not A18R, by a vaccinia core protein L4R, an ssDNA binding protein","Bayliss C.D., Wilcockt D., Smith G.L.",00221317,"Journal of General Virology",77, 11,5,0,0,0,0,5
1996,"Serum albumin distribution in early treated anorexia nervosa","Smith G., Robinson P.H., Fleck A.",08999007,"Nutrition",12, 10,20,4,3,7,2,29
1996,"A mechanism for the inhibition of fever by a virus","Alcami A., Smith G.L.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",93, 20,56,3,5,8,0,64
1996,"Soluble interferon-? receptors encoded by poxviruses","Alcami A., Smith G.L.",01479571,"Comparative Immunology, Microbiology and Infectious Diseases",19, 4,23,1,2,3,1,27
1996,"Receptors for gamma-interferon encoded by poxviruses: Implications for the unknown origin of vaccinia virus","Alcami A., Smith G.L.",0966842X,"Trends in Microbiology",4, 8,24,0,1,1,2,27
1996,"Virus proteins that bind cytokines, chemokines or interferons","Smith G.L.",09527915,"Current Opinion in Immunology",8, 4,50,1,1,2,0,52
1996,"Ligation of double-stranded and single-stranded [oligo(dT)] DNA by vaccinia virus DNA ligase","Odell M., Kerr S.M., Smith G.L.",00426822,"Virology",221, 1,6,0,0,0,0,6
1996,"Vaccinia virions lacking core protein VP8 are deficient in early transcription","Wilcock D., Smith G.L.",0022538X,"Journal of Virology",70, 2,17,2,0,2,0,19
1996,"Vaccinia virion protein I8R has both DNA and RNA helicase activities: Implications for vaccinia virus transcription","Bayliss C.D., Smith G.L.",0022538X,"Journal of Virology",70, 2,22,1,1,2,0,24
1995,"The vaccinia virus A38L gene product is a 33-kDa integral membrane glycoprotein","Parkinson J.E., Sanderson C.M., Smith G.L.",00426822,"Virology",214, 1,21,3,3,6,0,27
1995,"Cytokine receptors encoded by poxviruses: A lesson in cytokine biology","Alcami A., Smith G.L.",01675699,"Immunology Today",16, 10,104,0,1,1,2,107
1995,"Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model","Kettle S., Blake N.W., Law K.M., Smith G.L.",00426822,"Virology",206, 1,44,4,3,7,1,52
1995,"Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes","Blake N.W., Kettle S., Law K.M., Gould K., Bastin J., Townsend A.R.M., Smith G.L.",00221317,"Journal of General Virology",76, 9,11,0,1,1,0,12
1995,"African swine fever virus gene j13L encodes a 25-27 kDa virion protein with variable numbers of amino acid repeats","Sun H., Jacobs S.C., Smith G.L., Dixon L.K., Parkhouse R.M.E.",00221317,"Journal of General Virology",76, 5,12,1,0,1,3,16
1995,"Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity","Symons J.A., Alcami A., Smith G.L.",00928674,"Cell",81, 4,178,20,13,33,9,220
1995,"Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity","Alcami A., Smith G.L.",0022538X,"Journal of Virology",69, 8,146,12,6,18,4,168
1994,"Vaccinia virus core protein VP8 is required for virus infectivity, but not for core protein processing or for INV and EEV formation","Wilcock D., Smith G.L.",00426822,"Virology",202, 1,18,3,0,3,0,21
1994,"Virus strategies for evasion of the host response to infection","Smith G.L.",0966842X,"Trends in Microbiology",2, 3,78,0,0,0,0,78
1994,"Nucleotide sequence of a 55 kbp region from the right end of the genome of a pathogenic African swine fever virus isolate (Malawi LIL20/1)","Dixon L.K., Twigg S.R.F., Baylis S.A., Vydelingum S., Bristow C., Hammond J.M., Smith G.L.",00221317,"Journal of General Virology",75, 7,35,0,2,2,2,39
1994,"Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus","Parkinson J.E., Smith G.L.",00426822,"Virology",204, 1,100,3,8,11,2,113
1994,"Deletion of fowlpox virus homologues of vaccinia virus genes between the 3?-hydroxysteroid dehydrogenase (A44L) and DNA ligase (A50R) genes","Skinner M.A., Moore J.B., Binns M.M., Smith G.L., Boursnell M.E.G.",00221317,"Journal of General Virology",75, 9,11,0,0,0,0,11
1993,"Inhibitors of cholesterol biosynthesis. 1. 3,5-dihydroxy-7-(N-imidazolyl)- 6-heptenoates and -heptanoates, a novel series of HMG-CoA reductase inhibitors","Chan C., Lamont R.B., Lester M.G., Pritchard J.M., Ross B.C., Scicinski J.J., Spooner S.J., Smith G., Steeples I.P., Watson N.S., Bailey E.J., Hartley C.D., Hayman D.F., Hutson J.L., Inglis G.G.A., Jones P.S., Keeling S.E., Kirk B.E.",00222623,"Journal of Medicinal Chemistry",36, 23,6,1,1,2,2,10
1993,"Characterization of vaccinia virus gene B12R","Banham A.H., Smith G.L.",00221317,"Journal of General Virology",74, 12,9,0,1,1,0,10
1993,"Cytokine receptors encoded by poxviruses: A lesson in cytokine biology","Alcami A., Smith G.L.",01662236,"Trends in Neurosciences",16, 10,0,0,0,0,0,0
1993,"The fundamental parameters of the chromospherically active K2 dwarf ? Eridani","Drake J.J., Smith G.",0004637X,"Astrophysical Journal",412, 2,29,2,1,3,0,32
1993,"Comment on the paper by Shchelkunov et al. (1993) FEBS Letters 319, 80-83. Two genes encoding poxvirus cytokine receptors are disrupted or deleted in variola virus","Alcami A., Smith G.L.",00145793,"FEBS Letters",335, 1,7,0,0,0,0,7
1993,"African swine fever virus genome content and variability.","Dixon L.K., Baylis S.A., Vydelingum S., Twigg S.R., Hammond J.M., Hingamp P.M., Bristow C., Wilkinson P.J., Smith G.L.",09391983,"Archives of virology. Supplementum",7, ,3,0,0,0,0,3
1993,"Duplicated genes within the variable right end of the genome of a pathogenic isolate of African swine fever virus","Vydelingum S., Baylis S.A., Bristow C., Smith G.L., Dixon L.K.",00221317,"Journal of General Virology",74, 10,17,0,0,0,1,18
1993,"The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence","Engelstad M., Smith G.L.",00426822,"Virology",194, 2,90,4,7,11,4,105
1993,"Phosphorylation of ribosomal proteins by the vaccinia virus B1R protein kinase","Banham A.H., Leader D.P., Smith G.L.",00145793,"FEBS Letters",321, 1,11,1,0,1,0,12
1993,"Three African swine fever virus genes encoding proteins with homology to putative helicases of vaccinia virus","Baylis S.A., Twigg S.R.F., Vydelingum S., Dixon L.K., Smith G.L.",00221317,"Journal of General Virology",74, 9,2,1,0,1,1,4
1993,"African swine fever virus encodes a serine protein kinase which is packaged into virions","Baylis S.A., Banham A.H., Vydelingum S., Dixon L.K., Smith G.L.",0022538X,"Journal of Virology",67, 8,7,0,1,1,1,9
1993,"Vaccinia virus glycoproteins and immune evasion","Smith G.L.",00221317,"Journal of General Virology",74, 9,42,1,1,2,0,44
1992,"Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions","Banham A.H., Smith G.L.",00426822,"Virology",191, 2,41,2,1,3,1,45
1992,"African swine fever virus encodes a gene with extensive homology to type II DNA topoisomerases","Baylis S.A., Dixon L.K., Vydelingum S., Smith G.L.",00222836,"Journal of Molecular Biology",228, 3,7,1,0,1,2,10
1992,"A soluble receptor for interleukin-1? encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection","Alcami A., Smith G.L.",00928674,"Cell",71, 1,196,6,6,12,7,215
1992,"Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor.","Moore J.B., Smith G.L.",02614189,"EMBO Journal",11, 9,9,0,3,3,0,12
1992,"A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope","Engelstad M., Howard S.T., Smith G.L.",00426822,"Virology",188, 2,109,6,6,12,3,124
1992,"A vaccinia serine protease inhibitor which prevents virus-induced cell fusion","Law K.M., Smith G.L.",00221317,"Journal of General Virology",73, 3,27,4,2,6,1,34
1992,"Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress","Duncan S.A., Smith G.L.",0022538X,"Journal of Virology",66, 3,68,0,3,3,0,71
1992,"Vaccinia virus gene SalF5R is non-essential for virus replication in vitro and in vivo","Duncan S.A., Smith G.L.",00221317,"Journal of General Virology",73, 5,3,0,0,0,0,3
1992,"An African swine fever virus gene with homology to DNA ligases","Hammond J.F., Kerr S.M., Smith G.L., Dixon L.K.",03051048,"Nucleic Acids Research",20, 11,9,0,0,0,1,10
1992,"Steroid hormone synthesis by a vaccinia enzyme: A new type of virus virulence factor","Moore J.B., Smith G.L.",02614189,"EMBO Journal",11, 5,33,0,0,0,1,34
1992,"Corrigendum: Steroid hormone synthesis by a vaccinia enzyme: A new type of virus virulence factor (The EMBO Journal (1992) 11 (1973-1980))","Moore J.B., Smith G.L.",02614189,"EMBO Journal",11, 9,1,2,0,2,0,3
1992,"Nucleotide sequence of 21.8 kbp of variola major virus strain Harvey and comparison with vaccinia virus","Aguado B., Selmes I.P., Smith G.L.",00221317,"Journal of General Virology",73, 11,39,0,0,0,0,39
1991,"Professional organizations in the European meetings industry","Smith G.",02784319,"International Journal of Hospitality Management",10, 2,1,0,0,0,0,1
1991,"Vaccinia virus vectors for gene expression","Smith G.L.",09581669,"Current Opinion in Biotechnology",2, 5,5,0,0,0,0,5
1991,"Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat","Smith G.L., Chan Y.S., Howard S.T.",00221317,"Journal of General Virology",72, 6,67,0,3,3,2,72
1991,"Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily","Smith G.L., Chan Y.S.",00221317,"Journal of General Virology",72, 3,40,2,2,4,0,44
1991,"Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus","Forrester A.J., Sullivan V., Simmons A., Blacklaws B.A., Smith G.L., Nash A.A., Minson A.C.",00221317,"Journal of General Virology",72, 2,18,0,0,0,0,18
1991,"Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family","Howard S.T., Chan Y.S., Smith G.L.",00426822,"Virology",180, 2,66,1,1,2,0,68
1991,"Vaccinia virus DNA ligase is nonessential for virus replication: Recovery of plasmids from virus-infected cells","Kerr S.M., Smith G.L.",00426822,"Virology",180, 2,18,1,2,3,1,22
1991,"Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae","Hughes S.J., Johnston L.H., De Carlos A., Smith G.L.",00219258,"Journal of Biological Chemistry",266, 30,28,5,0,5,0,33
1991,"Vaccinia DNA ligase complements Saccharomyces cerevisiae cdc9, localizes in cytoplasmic factories and affects virulence and virus sensitivity to DNA damaging agents","Kerr S.M., Johnston L.H., Odell M., Duncan S.A., Law K.M., Smith G.L.",02614189,"EMBO Journal",10, 13,23,1,1,2,0,25
1990,"A complex between the MHC class I homologue encoded by human cytomegalovirus and ?2 microglobulin","Browne H., Smith G., Beck S., Minson T.",00280836,"Nature",347, 6295,88,4,10,14,1,103
1990,"IPTG-dependent vaccinia virus: Identification of a virus protein enabling virion envelopment by Golgi membrane and egress","Rodriguez J.F., Smith G.L.",03051048,"Nucleic Acids Research",18, 18,55,2,4,6,1,62
1990,"Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes","Zhou J., Crawford L., McLean L., Sun X., Stanley M., Almond N., Smith G.L.",00221317,"Journal of General Virology",71, 9,11,1,1,2,0,13
1990,"Inducible gene expression from vaccinia virus vectors","Rodriguez J.F., Smith G.L.",00426822,"Virology",177, 1,38,0,1,1,2,41
1990,"Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus","McLean C.S., Churcher M.J., Meinke J., Smith G.L., Higgins G., Stanley M., Minson A.C.",00219746,"Journal of Clinical Pathology",43, 6,24,2,3,5,0,29
1989,"Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases","Smith G.L., Chan Y.S., Kerr S.M.",03051048,"Nucleic Acids Research",17, 22,20,0,1,1,0,21
1989,"Vaccinia virus encodes a polypeptide with DNA ligase activity","Kerr S.M., Smith G.L.",03051048,"Nucleic Acids Research",17, 22,14,1,2,3,0,17
1989,"Two early vaccinia virus genes encode polypeptide related to protein kinases","Howard S.T., Smith G.L.",00221317,"Journal of General Virology",70, 12,7,0,0,0,0,7
1989,"Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors","Smith G.L., Howard S.T., Chan Y.S.",00221317,"Journal of General Virology",70, 9,42,1,3,4,1,47
1989,"Vaccinia virus encodes a thymidylate kinase gene: Sequence and transcriptional mapping","Smith G.L., De Carlos A., Chan Y.S.",03051048,"Nucleic Acids Research",17, 19,12,1,1,2,1,15
1988,"Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.","Townsend A., Bastin J., Gould K., Brownlee G., Andrew M., Coupar B., Boyle D., Chan S., Smith G.",00221007,"Journal of Experimental Medicine",168, 4,134,6,8,14,1,149
1988,"Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H","Cranage M.P., Smith G.L., Bell S.E., Hart H., Brown C., Bankier A.T., Tomlinson P., Barrell B.G., Minson T.C.",0022538X,"Journal of Virology",62, 4,43,2,1,3,0,46
1988,"Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses","Borysiewicz L.K., Hickling J.K., Graham S., Sinclair J., Cranage M.P., Smith G.L., Sissons J.G.P.",00221007,"Journal of Experimental Medicine",168, 3,107,2,10,12,1,120
1988,"The herpes simplex virus type 1 US7 gene product is a 66K glycoprotein and is a target for complement-dependent virus neutralization","Sullivan V., Smith G.L.",00221317,"Journal of General Virology",69, 4,3,0,0,0,0,3
1988,"Analysis of the L1 gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinant","Browne H.M., Churcher M.J., Stanley M.A., Smith G.L., Minson A.C.",00221317,"Journal of General Virology",69, 6,8,0,1,1,0,9
1987,"Recombinant vaccinia viruses as live vaccines.","Smith G.L.",04400607,"Hamatologie und Bluttransfusion",31, ,0,0,0,0,0,0
1987,"Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gG) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gG antibody.","Sullivan V., Smith G.L.",00221317,"Journal of General Virology",68, ,1,0,0,0,1,2
1987,"Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses","Smith G.L., Levin J.Z., Palese P., Moss B.",00426822,"Virology",160, 2,55,1,1,2,1,58
1987,"Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes","Gotch F., McMichael A., Smith G., Moss B.",00221007,"Journal of Experimental Medicine",165, 2,34,4,6,10,2,46
1986,"Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus","Cheng K.-C., Smith G.L., Moss B.",0022538X,"Journal of Virology",60, 2,20,2,0,2,0,22
1986,"Vaccinia virus expression vectors.","Mackett M., Smith G.L.",00221317,"The Journal of general virology",67, ,15,0,1,1,0,16
1986,"Vaccinia virus: An expression vector for genes from parasites","Smith G.L., Cheng K.-C., Moss B.",00311820,"Parasitology",92, ,3,0,0,0,0,3
1985,"Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype","Buller R.M.L., Smith G.L., Cremer K.",00280836,"Nature",317, 6040,86,9,8,17,4,107
1985,"Acute airway obstruction following tooth extraction in hereditary angioedema","Degroote D.F., Smith G.L., Huttula G.S.",02782391,"Journal of Oral and Maxillofacial Surgery",43, 1,11,1,0,1,0,12
1984,"Plasmodium knowlesi sporozoite antigen: Expression by infectious recombinant vaccinia virus","Smith G.L., Nigel Godson G., Nussenzweig V., Nussenzweig R.S., Barnwell J., Moss B.",00368075,"Science",224, 4647,0,0,0,0,0,0
1984,"Live recombinant vaccinia virus protects chimpanzees against hepatitis B","Moss B., Smith G.L., Gerin J.L., Purcell R.H.",00280836,"Nature",311, 5981,32,6,2,8,1,41
1984,"Plasmodium knowlesi sporozoite antigen: Expression by infectious recombinant vaccinia virus","Smith G.L., Godson G.N., Nussenzweig V.",00368075,"Science",224, 4647,4,0,0,0,0,4
1984,"General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes","Mackett M., Smith G.L., Moss B.",0022538X,"Journal of Virology",49, 3,145,3,4,7,4,156
1983,"Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters","Smith G.L., Murphy B.R., Moss B.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",80, 23 I,31,3,2,5,1,37
1983,"Infectious poxvirus vectors have capacity for at least 25,000 base pairs of foreign DNA","Smith G.L., Moss B.",03781119,"Gene",25, 1,47,2,1,3,3,53
1983,"Use of vaccinia virus as an infectious molecular cloning and expression vector.","Moss B., Smith G.L., Mackett M.",02752778,"Gene amplification and analysis",3, ,2,0,0,0,0,2
1983,"Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen","Smith G.L., Mackett M., Moss B.",00280836,"Nature",302, 5908,32,4,2,6,1,39
1982,"Vaccinia virus: A selectable eukaryotic cloning and expression vector","Mackett M., Smith G.L., Moss B.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",79, 23 I,126,7,6,13,2,141
1982,"Derivative spectroscopy and its applications in analysis","O'Haver T.C., Ahmad T.A., Chadburn B.P., Cottrell C.T., Fell A.F., Smith G., Gans P., Sneddon J., Bezur L., Michel R.G., Ottaway J.M., Miller J.N.",0144557X,"Analytical Proceedings",19, 1,12,1,1,2,1,15
1982,"Replication of the influenza virus genome","Smith G.L., Hay A.J.",00426822,"Virology",118, 1,14,3,2,5,2,21
1981,"Purification and characterization of multiplication-stimulating activity (MSA) carrier protein","Knauer D.J., Wagner F.W., Smith G.L.",,"Journal of Supramolecular and Cellular Biochemistry",15, 2,1,0,0,0,0,1
1980,"Purification, characterization and biological activity of multiplication-stimulating activity (MSA) carrier protein","Knauer D.J., Smith G.L.",00219525,"Journal of Cell Biology",87, 2,0,0,0,0,0,0
1980,"Identification of somatomedin-like polypeptides produced by mammary tumors of BALB/c mice","Knauer D.J., Iyer A.P., Banerjee M.R., Smith G.L.",00085472,"Cancer Research",40, 12,0,0,0,0,0,0
1980,"Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein","Knauer D.J., Smith G.L.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",77, 12,24,1,0,1,0,25
1977,"Increased ouabain sensitive 86ribidium+ uptake after mitogenic stimulation of quiescent chicken embryo fibroblasts with purified multiplication stimulating activity","Smith G.L.",00219525,"Journal of Cell Biology",73, 3,1,0,1,1,0,2
1968,"Interpretation of foreign-gas broadening and shift in krypton","Vaughan J.M., Smith G.",0031899X,"Physical Review",166, 1,0,0,0,0,0,0
1909,"The presence of hæmoglobin in invertebrate blood [2]","Smith G.",00280836,"Nature",81, 2083,0,0,0,0,0,0
